-+ 0.00%
-+ 0.00%
-+ 0.00%

PEOPLE LIVING WITH FAMILIAL CHYLOMICRONAEMIA SYNDROME (FCS) IN GERMANY HAVE ACCESS TO REDEMPLO® (PLOZASIRAN) AS A NEW TREATMENT OPTION TO REDUCE TRIGLYCERIDES

Reuters·08/17/2026 13:33:07

Please log in to view news